Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(Isopropylamino)diphenylamine
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Epicutaneous
01
Overview
4-(Isopropylamino)diphenylamine, also known as IPPD, is a small molecule chemical compound primarily used as an antiozonant in rubber manufacturing, especially for tires. In the medical context, it is approved for use in allergenic epicutaneous patch tests to aid in the diagnosis of allergic contact dermatitis (ACD) in individuals aged six years and older. It is a known allergen and can cause sensitivity reactions detectable by clinical patch testing. The mechanism of action related to its diagnostic use has not been specified[1][3].
- Other names
- N-isopropyl-N'-phenyl-p-phenylenediamineN1-isopropyl-N4-phenylbenzene-1,4-diamine
Beyond the preview
Go deeper on 4-(Isopropylamino)diphenylamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-(Isopropylamino)diphenylamine.